Literature DB >> 9790311

Human T- and B-cell reactivity to the 16kDa alpha-crystallin protein of Mycobacterium tuberculosis.

R J Wilkinson1, K A Wilkinson, K A De Smet, K Haslov, G Pasvol, M Singh, I Svarcova, J Ivanyi.   

Abstract

The attributes of immunodominance, predominant expression during mycobacterial dormancy and restriction to the Mycobacterium tuberculosis complex make the 16 kDa protein an important candidate for the study of the immune response in humans. We therefore investigated the relationship between T- and B-cell reactivity to the recombinant antigen and disease in a total of 127 subjects. The percentage of T-cell responders towards both the intact antigen and its permissively recognised peptide 16p91-110 was highest in healthy bacillus Calmette-Guérin (BCG)-sensitized controls (96% and 68%, respectively) and lowest in those with extensive untreated tuberculosis (26% and 18%) (P < 0.001). By contrast, antibody levels (ABT50 > 100) were highest in patients with extensive disease (46-50%) (P < 0.005). There was significantly higher production of IFN-gamma in the BCG-sensitized controls by comparison with untreated patients (P < 0.05), but complete antituberculous chemotherapy abolished this deficit in patients. The significance of these findings to immunodiagnosis and protective immunity is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9790311     DOI: 10.1046/j.1365-3083.1998.00420.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  36 in total

1.  Recessive expression of the H2A-controlled immune response phenotype depends critically on antigen dose.

Authors:  G Barcenas-Morales; M Merkenschlager; F Wahid; R Döffinger; J Ivanyi
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

2.  Microaerophilic induction of the alpha-crystallin chaperone protein homologue (hspX) mRNA of Mycobacterium tuberculosis.

Authors:  L E Desjardin; L G Hayes; C D Sohaskey; L G Wayne; K D Eisenach
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

3.  Diagnostic significance of humoral immune responses to recombinant antigens of Mycobacterium tuberculosis in patients with pleural tuberculosis.

Authors:  S Sumi; V V Radhakrishnan
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 4.  Antigens for CD4 and CD8 T cells in tuberculosis.

Authors:  Cecilia S Lindestam Arlehamn; David Lewinsohn; Alessandro Sette; Deborah Lewinsohn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-22       Impact factor: 6.915

Review 5.  Latent tuberculosis: what the host "sees"?

Authors:  Hannah P Gideon; JoAnne L Flynn
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

6.  Antibody profiles characteristic of Mycobacterium tuberculosis infection state.

Authors:  Amy Davidow; Ganga V Kanaujia; Lanbo Shi; Justin Kaviar; Xudong Guo; Nackmoon Sung; Gilla Kaplan; Dick Menzies; Maria L Gennaro
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

7.  Acetylome analysis reveals diverse functions of lysine acetylation in Mycobacterium tuberculosis.

Authors:  Fengying Liu; Mingkun Yang; Xude Wang; Shanshan Yang; Jing Gu; Jie Zhou; Xian-En Zhang; Jiaoyu Deng; Feng Ge
Journal:  Mol Cell Proteomics       Date:  2014-09-01       Impact factor: 5.911

Review 8.  Latent tuberculosis infection: myths, models, and molecular mechanisms.

Authors:  Noton K Dutta; Petros C Karakousis
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

9.  Immune responses to mycobacterial antigens in the Gambian population: implications for vaccines and immunodiagnostic test design.

Authors:  Johan Vekemans; Martin O C Ota; Jackson Sillah; Katherine Fielding; Mark R Alderson; Yasir A W Skeiky; Wilfried Dalemans; Keith P W J McAdam; Christian Lienhardt; Arnaud Marchant
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  Epitope-specific antibody levels demonstrate recognition of new epitopes and changes in titer but not affinity during treatment of tuberculosis.

Authors:  Graham H Bothamley
Journal:  Clin Diagn Lab Immunol       Date:  2004-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.